Chirag K. Patel - Mar 3, 2025 Form 4 Insider Report for Amneal Pharmaceuticals, Inc. (AMRX)

Signature
/s/ Denis Butkovic, Attorney-in-Fact
Stock symbol
AMRX
Transactions as of
Mar 3, 2025
Transactions value $
-$2,867,328
Form type
4
Date filed
3/5/2025, 07:33 PM
Previous filing
Mar 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMRX Class A Common Stock Options Exercise +580K +113.1% 1.09M Mar 3, 2025 Direct F1
transaction AMRX Class A Common Stock Tax liability -$2.45M -280K -25.59% $8.76 813K Mar 3, 2025 Direct F2
transaction AMRX Class A Common Stock Options Exercise +92.6K +11.39% 905K Mar 4, 2025 Direct F3, F4
transaction AMRX Class A Common Stock Tax liability -$419K -47.4K -5.23% $8.84 858K Mar 4, 2025 Direct F5
holding AMRX Class A Common Stock 21.3M Mar 3, 2025 By Family Trusts

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMRX Performance-Based Restricted Stock Units Options Exercise $0 -580K -100% $0.00 0 Mar 3, 2025 Class A Common Stock 580K Direct F1
transaction AMRX Performance-Based Restricted Stock Units Award $0 +890K $0.00 890K Mar 3, 2025 Class A Common Stock 890K Direct F6, F7
transaction AMRX Restricted Stock Units Award $0 +240K $0.00 240K Mar 3, 2025 Class A Common Stock 240K Direct F4, F8
transaction AMRX Restricted Stock Units Options Exercise $0 -92.6K -25% $0.00 278K Mar 4, 2025 Class A Common Stock 92.6K Direct F4, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. On March 3, 2022, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. These units were certified as meeting the performance threshold that resulted in vesting of 100% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2025 and settled into shares of Class A Common Stock on a one-for-one basis. Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 2.
F2 Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of performance-based restricted stock units.
F3 Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 5.
F4 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F5 Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.
F6 Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F7 Represents a performance-based restricted stock unit grant of 445,205 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units will be deemed earned and vested when settled into shares of Class A Common Stock shortly after February 28, 2028, the last day of the performance period.
F8 The restricted stock units vest in four equal annual installments beginning on March 3, 2026.
F9 On March 4, 2024, the Reporting Person was granted 370,370 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.